NF-κB, the first quarter-century: remarkable progress and outstanding questions.

The ability to sense and adjust to the environment is crucial to life. For multicellular organisms, the ability to respond to external changes is essential not only for survival but also for normal development and physiology. Although signaling events can directly modify cellular function, typically signaling acts to alter transcriptional responses to generate both transient and sustained changes. Rapid, but transient, changes in gene expression are mediated by inducible transcription factors such as NF-κB. For the past 25 years, NF-κB has served as a paradigm for inducible transcription factors and has provided numerous insights into how signaling events influence gene expression and physiology. Since its discovery as a regulator of expression of the κ light chain gene in B cells, research on NF-κB continues to yield new insights into fundamental cellular processes. Advances in understanding the mechanisms that regulate NF-κB have been accompanied by progress in elucidating the biological significance of this transcription factor in various physiological processes. NF-κB likely plays the most prominent role in the development and function of the immune system and, not surprisingly, when dysregulated, contributes to the pathophysiology of inflammatory disease. As our appreciation of the fundamental role of inflammation in disease pathogenesis has increased, so too has the importance of NF-κB as a key regulatory molecule gained progressively greater significance. However, despite the tremendous progress that has been made in understanding the regulation of NF-κB, there is much that remains to be understood. In this review, we highlight both the progress that has been made and the fundamental questions that remain unanswered after 25 years of study.

[1]  R. Beyaert,et al.  Linear ubiquitination in NF-κB signaling and inflammation: What we do understand and what we do not. , 2011, Biochemical pharmacology.

[2]  O. Kallioniemi,et al.  SHARPIN is an endogenous inhibitor of β1-integrin activation , 2011, Nature Cell Biology.

[3]  J. Ragoussis,et al.  Principles of dimer-specific gene regulation revealed by a comprehensive characterization of NF-κB family DNA binding , 2011, Nature Immunology.

[4]  R. Flavell,et al.  The E3 ligase Itch and deubiquitinase Cyld co-operatively regulate Tak1 and inflammation , 2011, Nature Immunology.

[5]  M. Chance,et al.  The inducible kinase IKKi is required for IL-17-dependent signaling associated with neutrophilia and pulmonary inflammation , 2011, Nature Immunology.

[6]  T. Hamilton,et al.  Treatment with IL-17 prolongs the half-life of chemokine CXCL1 mRNA via the adaptor TRAF5 and the splicing-regulatory factor SF2 (ASF) , 2011, Nature Immunology.

[7]  Zhijian J. Chen,et al.  MAVS Forms Functional Prion-like Aggregates to Activate and Propagate Antiviral Innate Immune Response , 2011, Cell.

[8]  Michael Karin,et al.  Inflammation meets cancer, with NF-κB as the matchmaker , 2011, Nature Immunology.

[9]  M. Karin,et al.  Expanding TRAF function: TRAF3 as a tri-faced immune regulator , 2011, Nature Reviews Immunology.

[10]  Daniel E. Zak,et al.  Systems analysis identifies an essential role for SHANK-associated RH domain-interacting protein (SHARPIN) in macrophage Toll-like receptor 2 (TLR2) responses , 2011, Proceedings of the National Academy of Sciences.

[11]  H. Inoko,et al.  NFKBIL1 Confers Resistance to Experimental Autoimmune Arthritis Through the Regulation of Dendritic Cell Functions , 2011, Scandinavian journal of immunology.

[12]  F. Chan,et al.  Faculty Opinions recommendation of Functional complementation between FADD and RIP1 in embryos and lymphocytes. , 2011 .

[13]  G. Altan-Bonnet,et al.  A Cascade of Protein Kinase C Isozymes Promotes Cytoskeletal Polarization in T Cells , 2011, Nature Immunology.

[14]  Xuliang Jiang,et al.  Crystal structure of inhibitor of kappaB kinase beta. , 2011 .

[15]  M. Nishida,et al.  Heterologous down-regulation of angiotensin type 1 receptors by purinergic P2Y2 receptor stimulation through S-nitrosylation of NF-κB , 2011, Proceedings of the National Academy of Sciences.

[16]  Peter Scheurich,et al.  TNFR1‐induced activation of the classical NF‐κB pathway , 2011, The FEBS journal.

[17]  Anthony W. Purcell,et al.  Linear ubiquitination prevents inflammation and regulates immune signalling , 2011, Nature.

[18]  B. Maček,et al.  SHARPIN forms a linear ubiquitin ligase complex regulating NF-κB activity and apoptosis , 2011, Nature.

[19]  Y. Saeki,et al.  SHARPIN is a component of the NF-κB-activating linear ubiquitin chain assembly complex , 2011, Nature.

[20]  D. Vaux,et al.  In TNF-stimulated Cells, RIPK1 Promotes Cell Survival by Stabilizing TRAF2 and cIAP1, which Limits Induction of Non-canonical NF-κB and Activation of Caspase-8* , 2011, The Journal of Biological Chemistry.

[21]  S. Ghosh,et al.  NF-κB in immunobiology , 2011, Cell Research.

[22]  S. Shoelson,et al.  Type 2 diabetes as an inflammatory disease , 2011, Nature Reviews Immunology.

[23]  S. Ghosh,et al.  NF-κB, inflammation, and metabolic disease. , 2011, Cell metabolism.

[24]  D. Kreisel,et al.  Bcl3 prevents acute inflammatory lung injury in mice by restraining emergency granulopoiesis. , 2011, The Journal of clinical investigation.

[25]  Patrick G. A. Pedrioli,et al.  RNAi‐based screening identifies the Mms22L–Nfkbil2 complex as a novel regulator of DNA replication in human cells , 2010, The EMBO journal.

[26]  P. Meier,et al.  IAPs: from caspase inhibitors to modulators of NF-κB, inflammation and cancer , 2010, Nature Reviews Cancer.

[27]  Grant W. Brown,et al.  The MMS22L-TONSL complex mediates recovery from replication stress and homologous recombination. , 2010, Molecular cell.

[28]  C. Ponting,et al.  Identification of the MMS22L-TONSL complex that promotes homologous recombination. , 2010, Molecular cell.

[29]  J Wade Harper,et al.  A genome-wide camptothecin sensitivity screen identifies a mammalian MMS22L-NFKBIL2 complex required for genomic stability. , 2010, Molecular cell.

[30]  S. Robson,et al.  Nucleosome-Interacting Proteins Regulated by DNA and Histone Methylation , 2010, Cell.

[31]  G. Dittmar,et al.  A cytoplasmic ATM-TRAF6-cIAP1 module links nuclear DNA damage signaling to ubiquitin-mediated NF-κB activation. , 2010, Molecular cell.

[32]  Sankar Ghosh,et al.  Constitutively active NF-kappaB triggers systemic TNFalpha-dependent inflammation and localized TNFalpha-independent inflammatory disease. , 2010, Genes & development.

[33]  Pascal Meier,et al.  IAPs: from caspase inhibitors to modulators of NF-κB, inflammation and cancer , 2010, Nature Reviews Cancer.

[34]  A. Boulares,et al.  Poly(ADP-Ribose) Polymerase-1 Is a Determining Factor in Crm1-Mediated Nuclear Export and Retention of p65 NF-κB upon TLR4 Stimulation , 2010, The Journal of Immunology.

[35]  A. Miyajima,et al.  IκBη, a nuclear IκB protein, positively regulates the NF-κB–mediated expression of proinflammatory cytokines , 2010, Proceedings of the National Academy of Sciences.

[36]  Zhijian J. Chen,et al.  Reconstitution of the RIG-I Pathway Reveals a Signaling Role of Unanchored Polyubiquitin Chains in Innate Immunity , 2010, Cell.

[37]  Jiahuai Han,et al.  Receptor-interacting protein (RIP) kinase family , 2010, Cellular and Molecular Immunology.

[38]  S. Akira,et al.  IκBζ regulates TH17 development by cooperating with ROR nuclear receptors , 2010, Nature.

[39]  C. Ware,et al.  Allosteric Regulation of the Ubiquitin:NIK and Ubiquitin:TRAF3 E3 Ligases by the Lymphotoxin-β Receptor* , 2010, The Journal of Biological Chemistry.

[40]  D. Vaux,et al.  RIPK1 is not essential for TNFR1-induced activation of NF-κB , 2010, Cell Death and Differentiation.

[41]  K. Blackwell,et al.  The RING domain of TRAF2 plays an essential role in the inhibition of TNFalpha-induced cell death but not in the activation of NF-kappaB. , 2010, Journal of molecular biology.

[42]  Christoph H. Emmerich,et al.  Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction. , 2009, Molecular cell.

[43]  T. Lawrence The nuclear factor NF-kappaB pathway in inflammation. , 2009, Cold Spring Harbor perspectives in biology.

[44]  Tina N. Davis,et al.  Systematic in vivo structure-function analysis of p300 in hematopoiesis. , 2009, Blood.

[45]  B. Lamothe,et al.  Structural basis for the lack of E2 interaction in the RING domain of TRAF2. , 2009, Biochemistry.

[46]  D. Baltimore,et al.  Regulation of NF-κB activity through lysine monomethylation of p65 , 2009, Proceedings of the National Academy of Sciences.

[47]  C. McCall,et al.  Dynamic and Selective Nucleosome Repositioning during Endotoxin Tolerance* , 2009, The Journal of Biological Chemistry.

[48]  M. Karin NF-kappaB as a critical link between inflammation and cancer. , 2009, Cold Spring Harbor perspectives in biology.

[49]  Zhijian J. Chen,et al.  A ubiquitin replacement strategy in human cells reveals distinct mechanisms of IKK activation by TNFalpha and IL-1beta. , 2009, Molecular cell.

[50]  B. Cairns The logic of chromatin architecture and remodelling at promoters , 2009, Nature.

[51]  Zhijian J. Chen,et al.  Direct Activation of Protein Kinases by Unanchored Polyubiquitin Chains , 2009, Nature.

[52]  M. Mann,et al.  Mapping of lysine monomethylation of linker histones in human breast and its cancer. , 2009, Journal of proteome research.

[53]  S. Gaffen Structure and signalling in the IL-17 receptor family , 2009, Nature Reviews Immunology.

[54]  Alexander Hoffmann,et al.  Kinetic control of negative feedback regulators of NF-κB/RelA determines their pathogen- and cytokine-receptor signaling specificity , 2009, Proceedings of the National Academy of Sciences.

[55]  John Yang,et al.  Bcl3 Interacts Cooperatively with Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Coactivator 1α To Coactivate Nuclear Receptors Estrogen-Related Receptor α and PPARα , 2009, Molecular and Cellular Biology.

[56]  Zhijian J. Chen,et al.  Ubiquitylation in innate and adaptive immunity , 2009, Nature.

[57]  Nobuhiro Suzuki,et al.  Specific Recognition of Linear Ubiquitin Chains by NEMO Is Important for NF-κB Activation , 2009, Cell.

[58]  A. Haas Linear polyubiquitylation: the missing link in NF–κB signalling , 2009, Nature Cell Biology.

[59]  S. Akira,et al.  Involvement of linear polyubiquitylation of NEMO in NF-κB activation , 2009, Nature Cell Biology.

[60]  T. Hamilton,et al.  IL-17 Signaling for mRNA Stabilization Does Not Require TNF Receptor-Associated Factor 61 , 2009, The Journal of Immunology.

[61]  M. Kasuga,et al.  Phosphoinositide-dependent kinase 1 integrates T cell receptor and CD28 co-receptor signaling to effect NF-κB induction and T cell activation , 2009, Nature Immunology.

[62]  A. Strasser,et al.  FADD and the NF‐κB family member Bcl‐3 regulate complementary pathways to control T‐cell survival and proliferation , 2008, Immunology.

[63]  J. Keats,et al.  Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-κB signaling , 2008, Nature Immunology.

[64]  N. Sharma,et al.  The Proto-Oncogene Bcl3, Induced by Tax, Represses Tax-Mediated Transcription via p300 Displacement from the Human T-Cell Leukemia Virus Type 1 Promoter , 2008, Journal of Virology.

[65]  George Kollias,et al.  Function of TRADD in tumor necrosis factor receptor 1 signaling and in TRIF-dependent inflammatory responses , 2008, Nature Immunology.

[66]  Zheng‐gang Liu,et al.  The function of TRADD in signaling through tumor necrosis factor receptor 1 and TRIF-dependent Toll-like receptors , 2008, Nature Immunology.

[67]  T. Mak,et al.  Beyond tumor necrosis factor receptor: TRADD signaling in toll-like receptors , 2008, Proceedings of the National Academy of Sciences.

[68]  J. Waring,et al.  Both cIAP1 and cIAP2 regulate TNFα-mediated NF-κB activation , 2008, Proceedings of the National Academy of Sciences.

[69]  P. Chilton,et al.  Impaired Bcl3 Up-regulation Leads to Enhanced Lipopolysaccharide-induced Interleukin (IL)-23P19 Gene Expression in IL-10–/– Mice* , 2008, Journal of Biological Chemistry.

[70]  A. Hoffmann,et al.  Stabilization of RelB Requires Multidomain Interactions with p100/p52* , 2008, Journal of Biological Chemistry.

[71]  S. Ghosh,et al.  Repression of gene expression by unphosphorylated NF-kappaB p65 through epigenetic mechanisms. , 2008, Genes & development.

[72]  Alexei Degterev,et al.  Identification of RIP1 kinase as a specific cellular target of necrostatins. , 2008, Nature chemical biology.

[73]  G. Cheng,et al.  Control of canonical NF-κB activation through the NIK–IKK complex pathway , 2008, Proceedings of the National Academy of Sciences.

[74]  S. Ghosh,et al.  Shared Principles in NF-κB Signaling , 2008, Cell.

[75]  P. Lucas,et al.  A critical role of RICK/RIP2 polyubiquitination in Nod‐induced NF‐κB activation , 2008 .

[76]  J. Ninomiya-Tsuji,et al.  TAK1 Is a Central Mediator of NOD2 Signaling in Epidermal Cells* , 2008, Journal of Biological Chemistry.

[77]  S. Ghosh,et al.  Phosphorylation of Serine 68 in the IκB Kinase (IKK)-binding Domain of NEMO Interferes with the Structure of the IKK Complex and Tumor Necrosis Factor-α-induced NF-κB Activity* , 2008, Journal of Biological Chemistry.

[78]  S. Maeda,et al.  IκB kinase β–induced phosphorylation of CARMA1 contributes to CARMA1–Bcl10–MALT1 complex formation in B cells , 2007, The Journal of experimental medicine.

[79]  D. Greetham,et al.  Functional characterization of NF-κB inhibitor-like protein 1 (NFκBIL1), a candidate susceptibility gene for rheumatoid arthritis , 2007 .

[80]  Vishva M. Dixit,et al.  IAP Antagonists Induce Autoubiquitination of c-IAPs, NF-κB Activation, and TNFα-Dependent Apoptosis , 2007, Cell.

[81]  Seda Çöl Arslan,et al.  Malt1 ubiquitination triggers NF‐κB signaling upon T‐cell activation , 2007 .

[82]  H. E. Marshall,et al.  NOS2 Regulation of NF-κB by S-Nitrosylation of p65* , 2007, Journal of Biological Chemistry.

[83]  M. Karin,et al.  Inhibitor ?B Kinase Binding by Inhibitor ?B Kinase ? , 2007 .

[84]  T. Ohshima,et al.  BCL3 Acts as a Negative Regulator of Transcription from the Human T-cell Leukemia Virus Type 1 Long Terminal Repeat through Interactions with TORC3* , 2007, Journal of Biological Chemistry.

[85]  T. Hamilton,et al.  IL-17 Enhances Chemokine Gene Expression through mRNA Stabilization1 , 2007, The Journal of Immunology.

[86]  C. McCall,et al.  Epigenetic Silencing of Tumor Necrosis Factor α during Endotoxin Tolerance* , 2007, Journal of Biological Chemistry.

[87]  R. Kornberg The molecular basis of eukaryotic transcription , 2007, Proceedings of the National Academy of Sciences.

[88]  R. Carmody,et al.  Negative Regulation of Toll-Like Receptor Signaling by NF-κB p50 Ubiquitination Blockade , 2007, Science.

[89]  M. Kumar,et al.  Functional Role for IκBNS in T Cell Cytokine Regulation As Revealed by Targeted Gene Disruption1 , 2007, The Journal of Immunology.

[90]  R. Jaenisch,et al.  A Chromatin Landmark and Transcription Initiation at Most Promoters in Human Cells , 2007, Cell.

[91]  L. Cantley,et al.  Coordinated Regulation of Toll-Like Receptor and NOD2 Signaling by K63-Linked Polyubiquitin Chains , 2007, Molecular and Cellular Biology.

[92]  Jiahuai Han,et al.  XIAP induces NF-kappaB activation via the BIR1/TAB1 interaction and BIR1 dimerization. , 2007, Molecular cell.

[93]  T. Kaisho,et al.  PDLIM2-mediated termination of transcription factor NF-κB activation by intranuclear sequestration and degradation of the p65 subunit , 2007, Nature Immunology.

[94]  Hana Kim,et al.  A Fourth IκB Protein within the NF-κB Signaling Module , 2007, Cell.

[95]  X. Mao,et al.  COMMD1 promotes the ubiquitination of NF‐κB subunits through a cullin‐containing ubiquitin ligase , 2007, The EMBO journal.

[96]  C. Dong,et al.  Act1 Adaptor Protein Is an Immediate and Essential Signaling Component of Interleukin-17 Receptor* , 2006, Journal of Biological Chemistry.

[97]  T. McKeithan,et al.  BCL3 is induced by IL-6 via Stat3 binding to intronic enhancer HS4 and represses its own transcription , 2006, Oncogene.

[98]  S. Gerondakis,et al.  Unravelling the complexities of the NF-κB signalling pathway using mouse knockout and transgenic models , 2006, Oncogene.

[99]  A. Hoffmann,et al.  Transcriptional regulation via the NF-κB signaling module , 2006, Oncogene.

[100]  G. Courtois,et al.  Mutations in the NF-κB signaling pathway: implications for human disease , 2006, Oncogene.

[101]  T. Gilmore Introduction to NF-κB: players, pathways, perspectives , 2006, Oncogene.

[102]  G. Cheng,et al.  Rescue of TRAF3-null mice by p100 NF-κB deficiency , 2006, The Journal of experimental medicine.

[103]  Keiji Tanaka,et al.  A ubiquitin ligase complex assembles linear polyubiquitin chains , 2006, The EMBO journal.

[104]  Michael Karin,et al.  Regulation and Function of IKK and IKK-Related Kinases , 2006, Science's STKE.

[105]  M. Hochstrasser,et al.  Modification of proteins by ubiquitin and ubiquitin-like proteins. , 2006, Annual review of cell and developmental biology.

[106]  S. Ghosh,et al.  Dimerization of the IκB Kinase-Binding Domain of NEMO Is Required for Tumor Necrosis Factor Alpha-Induced NF-κB Activity , 2006, Molecular and Cellular Biology.

[107]  C. McCall,et al.  Induction of RelB Participates in Endotoxin Tolerance1 , 2006, The Journal of Immunology.

[108]  Shao-Cong Sun,et al.  β-TrCP binding and processing of NF-κB2/p100 involve its phosphorylation at serines 866 and 870 , 2006 .

[109]  K. Ishii,et al.  Key function for the Ubc13 E2 ubiquitin-conjugating enzyme in immune receptor signaling , 2006, Nature Immunology.

[110]  A. Strasser,et al.  The NF-κB regulator Bcl-3 and the BH3-only proteins Bim and Puma control the death of activated T cells , 2006 .

[111]  J. Sprent,et al.  Regulation of naive T cell function by the NF-κB2 pathway , 2006, Nature Immunology.

[112]  D. Brautigan,et al.  Protein Phosphatase 6 Subunit with Conserved Sit4-associated Protein Domain Targets IκBϵ* , 2006, Journal of Biological Chemistry.

[113]  Alexander Hoffmann,et al.  IκBɛ provides negative feedback to control NF-κB oscillations, signaling dynamics, and inflammatory gene expression , 2006, The Journal of cell biology.

[114]  M. Karin Nuclear factor-κB in cancer development and progression , 2006, Nature.

[115]  Ramin Massoumi,et al.  Cyld Inhibits Tumor Cell Proliferation by Blocking Bcl-3-Dependent NF-κB Signaling , 2006, Cell.

[116]  G. Ghosh,et al.  The 20S proteasome processes NF‐κB1 p105 into p50 in a translation‐independent manner , 2006, The EMBO journal.

[117]  Katsuaki Sato,et al.  Regulatory dendritic cells act as regulators of acute lethal systemic inflammatory response. , 2006, Blood.

[118]  Gabriel Pineda,et al.  Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. , 2006, Molecular cell.

[119]  James A. Cuff,et al.  A Bivalent Chromatin Structure Marks Key Developmental Genes in Embryonic Stem Cells , 2006, Cell.

[120]  S. Srinivasula,et al.  Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-κB activation , 2006, Nature Cell Biology.

[121]  Y. You,et al.  Ubiquitination of RIP Is Required for Tumor Necrosis Factor α-induced NF-κB Activation* , 2006, Journal of Biological Chemistry.

[122]  S. Smale,et al.  Selective and antagonistic functions of SWI/SNF and Mi-2beta nucleosome remodeling complexes during an inflammatory response. , 2006, Genes & development.

[123]  M. Mayo,et al.  IκB Kinase α-Mediated Derepression of SMRT Potentiates Acetylation of RelA/p65 by p300 , 2006, Molecular and Cellular Biology.

[124]  J. Tschopp,et al.  PIDD Mediates NF-κB Activation in Response to DNA Damage , 2005, Cell.

[125]  William Arbuthnot Sir Lane,et al.  Acetylation of Poly(ADP-ribose) Polymerase-1 by p300/CREB-binding Protein Regulates Coactivation of NF-κB-dependent Transcription* , 2005, Journal of Biological Chemistry.

[126]  Dong-hai Wang,et al.  Phosphorylation of CARMA1 plays a critical role in T Cell receptor-mediated NF-kappaB activation. , 2005, Immunity.

[127]  David J. Rawlings,et al.  Phosphorylation of the CARMA1 Linker Controls NF-κB Activation , 2005 .

[128]  Katherine A. Fitzgerald,et al.  Rip1 Mediates the Trif-dependent Toll-like Receptor 3- and 4-induced NF-κB Activation but Does Not Contribute to Interferon Regulatory Factor 3 Activation* , 2005, Journal of Biological Chemistry.

[129]  A. Hoffmann,et al.  A c-Rel subdomain responsible for enhanced DNA-binding affinity and selective gene activation. , 2005, Genes & development.

[130]  Leonard Buckbinder,et al.  NF-κB RelA Phosphorylation Regulates RelA Acetylation , 2005, Molecular and Cellular Biology.

[131]  I. Verma,et al.  Distinct roles of IκB proteins in regulating constitutive NF-κB activity , 2005, Nature Cell Biology.

[132]  Leah Barrera,et al.  A high-resolution map of active promoters in the human genome , 2005, Nature.

[133]  Zhijian J. Chen Ubiquitin signalling in the NF-κB pathway , 2005, Nature Cell Biology.

[134]  S. Ghosh,et al.  PDK1 Nucleates T Cell Receptor-Induced Signaling Complex for NF-κB Activation , 2005, Science.

[135]  S. Akira,et al.  The Nuclear IκB Protein IκBNS Selectively Inhibits Lipopolysaccharide-Induced IL-6 Production in Macrophages of the Colonic Lamina Propria 1 , 2005, The Journal of Immunology.

[136]  T. Muta,et al.  Positive and Negative Regulation of Nuclear Factor-κB-mediated Transcription by IκB-ζ, an Inducible Nuclear Protein* , 2005, Journal of Biological Chemistry.

[137]  J. Tschopp,et al.  The RIP kinases: crucial integrators of cellular stress. , 2005, Trends in biochemical sciences.

[138]  Xinli Hu,et al.  Tyrosine Nitration on p65 , 2005, Molecular & Cellular Proteomics.

[139]  M. Mescher,et al.  Cutting Edge: Bcl-3 Up-Regulation by Signal 3 Cytokine (IL-12) Prolongs Survival of Antigen-Activated CD8 T Cells1 , 2005, The Journal of Immunology.

[140]  R. Corley,et al.  Reductions in IκBε and Changes in NF-κB Activity during B Lymphocyte Differentiation1 , 2005, The Journal of Immunology.

[141]  T. Muta,et al.  Stimulus-specific Induction of a Novel Nuclear Factor-κB Regulator, IκB-ζ, via Toll/Interleukin-1 Receptor Is Mediated by mRNA Stabilization* , 2004, Journal of Biological Chemistry.

[142]  Jae-Hyuck Shim,et al.  A Novel Ubiquitin-like Domain in IκB Kinase β Is Required for Functional Activity of the Kinase* , 2004, Journal of Biological Chemistry.

[143]  C. Müller,et al.  The Histone Octamer Is Invisible When NF-κB Binds to the Nucleosome* , 2004, Journal of Biological Chemistry.

[144]  S. Ghosh,et al.  Signaling to NF-kappaB. , 2004, Genes & development.

[145]  M. Kelliher,et al.  The Kinase Activity of Rip1 Is Not Required for Tumor Necrosis Factor-α-induced IκB Kinase or p38 MAP Kinase Activation or for the Ubiquitination of Rip1 by Traf2* , 2004, Journal of Biological Chemistry.

[146]  Douglas R. McDonald,et al.  RIP Links TLR4 to Akt and Is Essential for Cell Survival in Response to LPS Stimulation , 2004, The Journal of experimental medicine.

[147]  S. Akira,et al.  Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IκBζ , 2004, Nature.

[148]  S. Saccani,et al.  Degradation of Promoter-bound p65/RelA Is Essential for the Prompt Termination of the Nuclear Factor κB Response , 2004, The Journal of experimental medicine.

[149]  G. Courtois,et al.  The Trimerization Domain of Nemo Is Composed of the Interacting C-terminal CC2 and LZ Coiled-coil Subdomains* , 2004, Journal of Biological Chemistry.

[150]  Shao-Cong Sun,et al.  IκB Kinase Is an Essential Component of the Tpl2 Signaling Pathway , 2004, Molecular and Cellular Biology.

[151]  E. Harhaj,et al.  Regulation of the NF-κB-inducing Kinase by Tumor Necrosis Factor Receptor-associated Factor 3-induced Degradation* , 2004, Journal of Biological Chemistry.

[152]  G. Xiao,et al.  Induction of p100 Processing by NF-κB-inducing Kinase Involves Docking IκB Kinase α (IKKα) to p100 and IKKα-mediated Phosphorylation* , 2004, Journal of Biological Chemistry.

[153]  Zhijian J. Chen,et al.  The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. , 2004, Molecular cell.

[154]  F. Martinon,et al.  RIP1 is an essential mediator of Toll-like receptor 3–induced NF-κB activation , 2004, Nature Immunology.

[155]  W. Greene,et al.  Human T-cell Lymphotropic Virus Type 1 Tax Induction of Biologically Active NF-κB Requires IκB Kinase-1-mediated Phosphorylation of RelA/p65* , 2004, Journal of Biological Chemistry.

[156]  H. Shu,et al.  Identification of a ZU5 and Death Domain-containing Inhibitor of NF-κB* , 2004, Journal of Biological Chemistry.

[157]  A. Ciechanover,et al.  Mechanism of processing of the NF-κB2 p100 precursor: identification of the specific polyubiquitin chain-anchoring lysine residue and analysis of the role of NEDD8-modification on the SCFβ-TrCP ubiquitin ligase , 2004, Oncogene.

[158]  S. Akira,et al.  TIR domain-containing adaptors define the specificity of TLR signaling. , 2004, Molecular immunology.

[159]  Giulio Superti-Furga,et al.  A physical and functional map of the human TNF-α/NF-κB signal transduction pathway , 2004, Nature Cell Biology.

[160]  Z. Ronai,et al.  Ubiquitination and translocation of TRAF2 is required for activation of JNK but not of p38 or NF‐κB , 2004, The EMBO journal.

[161]  A. Ciechanover,et al.  Dual Effects of IκB Kinase β-Mediated Phosphorylation on p105 Fate: SCFβ-TrCP-Dependent Degradation and SCFβ-TrCP-Independent Processing , 2004, Molecular and Cellular Biology.

[162]  A. Ryo,et al.  Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. , 2003, Molecular cell.

[163]  S. Akira,et al.  IL-10-inducible Bcl-3 negatively regulates LPS-induced TNF-α production in macrophages , 2003 .

[164]  V. Dixit,et al.  Regulation of NF-κB-Dependent Lymphocyte Activation and Development by Paracaspase , 2003, Science.

[165]  Jürgen Ruland,et al.  Differential requirement for Malt1 in T and B cell antigen receptor signaling. , 2003, Immunity.

[166]  Baosheng Ge,et al.  NF-κB Regulates BCL3 Transcription in T Lymphocytes Through an Intronic Enhancer 1 , 2003, The Journal of Immunology.

[167]  H. Shu,et al.  Casper/c-FLIP is physically and functionally associated with NF-κB1 p105 , 2003 .

[168]  Takahiro Doi,et al.  Tumor Necrosis Factor-α-induced IKK Phosphorylation of NF-κB p65 on Serine 536 Is Mediated through the TRAF2, TRAF5, and TAK1 Signaling Pathway* , 2003, Journal of Biological Chemistry.

[169]  Eva E. Qwarnstrom,et al.  RelA Control of IκBα Phosphorylation , 2003, Journal of Biological Chemistry.

[170]  A. Durán,et al.  Essential role of RelA Ser311 phosphorylation by ζPKC in NF‐κB transcriptional activation , 2003 .

[171]  N. Perkins,et al.  p53 Represses Cyclin D1 Transcription through Down Regulation of Bcl-3 and Inducing Increased Association of the p52 NF-κB Subunit with Histone Deacetylase 1 , 2003, Molecular and Cellular Biology.

[172]  S. Ghosh,et al.  X-ray Crystal Structure of an IκBβ·NF-κB p65 Homodimer Complex* , 2003, Journal of Biological Chemistry.

[173]  T. Muta,et al.  IκB-ζ, a new anti-inflammatory nuclear protein induced by lipopolysaccharide, is a negative regulator for nuclear factor-κB , 2003 .

[174]  G. Cheng,et al.  The signaling adaptors and pathways activated by TNF superfamily. , 2003, Cytokine & growth factor reviews.

[175]  S. Saccani,et al.  Modulation of NF-κB Activity by Exchange of Dimers , 2003 .

[176]  H. Nakano,et al.  The death domain kinase RIP has an essential role in DNA damage-induced NF-kappa B activation. , 2003, Genes & development.

[177]  G. Haegeman,et al.  Transcriptional activation of the NF‐κB p65 subunit by mitogen‐ and stress‐activated protein kinase‐1 (MSK1) , 2003, The EMBO journal.

[178]  R. Surabhi,et al.  TAK1 is Critical for IκB Kinase-mediated Activation of the NF-κB Pathway , 2003 .

[179]  T. Muta,et al.  Essential roles for NF-κB and a Toll/IL-1 receptor domain-specific signal(s) in the induction of IκB-ζ , 2003 .

[180]  R. Hay,et al.  βTrCP-Mediated Proteolysis of NF-κB1 p105 Requires Phosphorylation of p105 Serines 927 and 932 , 2003, Molecular and Cellular Biology.

[181]  W. Greene,et al.  Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF‐κB , 2002, The EMBO journal.

[182]  D. Jin,et al.  Stimulation of IKK‐γ oligomerization by the human T‐cell leukemia virus oncoprotein Tax , 2002 .

[183]  A. Fong,et al.  S9, a 19 S Proteasome Subunit Interacting with Ubiquitinated NF-κB2/p100* , 2002, The Journal of Biological Chemistry.

[184]  Hao Wu,et al.  Distinct molecular mechanism for initiating TRAF6 signalling , 2002, Nature.

[185]  A. Fong,et al.  Genetic Evidence for the Essential Role of β-Transducin Repeat-containing Protein in the Inducible Processing of NF-κB2/p100* , 2002, The Journal of Biological Chemistry.

[186]  G. Courtois,et al.  NEMO Trimerizes through Its Coiled-coil C-terminal Domain* , 2002, The Journal of Biological Chemistry.

[187]  M. Hannink,et al.  Characterization of the Nuclear Import and Export Functions of IκBε* , 2002, The Journal of Biological Chemistry.

[188]  M. Karin,et al.  Missing Pieces in the NF-κB Puzzle , 2002, Cell.

[189]  E. Reinherz,et al.  Peptide-Induced Negative Selection of Thymocytes Activates Transcription of an NF-ΚB Inhibitor , 2002 .

[190]  S. Ghosh,et al.  The Phosphorylation Status of Nuclear NF-ΚB Determines Its Association with CBP/p300 or HDAC-1 , 2002 .

[191]  G. Bren,et al.  RelB Cellular Regulation and Transcriptional Activity Are Regulated by p100* , 2002, The Journal of Biological Chemistry.

[192]  W. Chang,et al.  The Sequence-specific DNA Binding of NF-κB Is Reversibly Regulated by the Automodification Reaction of Poly (ADP-ribose) Polymerase 1* , 2001, The Journal of Biological Chemistry.

[193]  S. Westerheide,et al.  The Putative Oncoprotein Bcl-3 Induces Cyclin D1 To Stimulate G1 Transition , 2001, Molecular and Cellular Biology.

[194]  T. Mak,et al.  Critical Roles of TRAF2 and TRAF5 in Tumor Necrosis Factor-induced NF-κB Activation and Protection from Cell Death* , 2001, The Journal of Biological Chemistry.

[195]  E. Zandi,et al.  Complete Reconstitution of Human IκB Kinase (IKK) Complex in Yeast , 2001, The Journal of Biological Chemistry.

[196]  Eric Verdin,et al.  Duration of Nuclear NF-κB Action Regulated by Reversible Acetylation , 2001, Science.

[197]  A. Brasier,et al.  NF-κB-inducible BCL-3 Expression Is an Autoregulatory Loop Controlling Nuclear p50/NF-κB1 Residence* , 2001, The Journal of Biological Chemistry.

[198]  J. Tschopp,et al.  NF-κB Signals Induce the Expression of c-FLIP , 2001, Molecular and Cellular Biology.

[199]  A. Ciechanover,et al.  Processing of p105 Is Inhibited by Docking of p50 Active Subunits to the Ankyrin Repeat Domain, and Inhibition Is Alleviated by Signaling via the Carboxyl-terminal Phosphorylation/ Ubiquitin-Ligase Binding Domain* , 2001, The Journal of Biological Chemistry.

[200]  A. Salmeron,et al.  Direct Phosphorylation of NF-κB1 p105 by the IκB Kinase Complex on Serine 927 Is Essential for Signal-induced p105 Proteolysis* , 2001, The Journal of Biological Chemistry.

[201]  S. Saccani,et al.  Two Waves of Nuclear Factor κb Recruitment to Target Promoters , 2001, The Journal of experimental medicine.

[202]  T. Muta,et al.  A Novel IκB Protein, IκB-ζ, Induced by Proinflammatory Stimuli, Negatively Regulates Nuclear Factor-κB in the Nuclei* , 2001, The Journal of Biological Chemistry.

[203]  P. Marrack,et al.  Immunological adjuvants promote activated T cell survival via induction of Bcl-3 , 2001, Nature Immunology.

[204]  K. Todokoro,et al.  Isolation of a Novel Interleukin-1-inducible Nuclear Protein Bearing Ankyrin-repeat Motifs* , 2001, The Journal of Biological Chemistry.

[205]  Y. Kadono,et al.  Segregation of TRAF6‐mediated signaling pathways clarifies its role in osteoclastogenesis , 2001, The EMBO journal.

[206]  M. Karin,et al.  IKKβ Is Essential for Protecting T Cells from TNFα-Induced Apoptosis , 2001 .

[207]  H. E. Marshall,et al.  Inhibition of NF-kappa B by S-nitrosylation. , 2001, Biochemistry.

[208]  S. Srinivasula,et al.  vCLAP, a Caspase-recruitment Domain-containing Protein of Equine Herpesvirus-2, Persistently Activates the IκB Kinases through Oligomerization of IKKγ* , 2001, The Journal of Biological Chemistry.

[209]  E. Harhaj,et al.  NF-κB-Inducing Kinase Regulates the Processing of NF-κB2 p100 , 2001 .

[210]  C. Scheidereit,et al.  Shared Pathways of IκB Kinase-Induced SCFβTrCP-Mediated Ubiquitination and Degradation for the NF-κB Precursor p105 and IκBα , 2001, Molecular and Cellular Biology.

[211]  S. Srinivasula,et al.  Activation of the IκB Kinases by RIP via IKKγ/NEMO-mediated Oligomerization* , 2000, The Journal of Biological Chemistry.

[212]  M. Morimatsu,et al.  MAIL, a novel nuclear IκB protein that potentiates LPS‐induced IL‐6 production , 2000 .

[213]  S. Westerheide,et al.  Tumor Necrosis Factor α-induced Phosphorylation of RelA/p65 on Ser529 Is Controlled by Casein Kinase II* , 2000, The Journal of Biological Chemistry.

[214]  A. Klippel,et al.  The IκB Kinase (IKK) Complex Is Tripartite and Contains IKKγ but Not IKAP as a Regular Component* , 2000, The Journal of Biological Chemistry.

[215]  P. Lucas,et al.  An Induced Proximity Model for NF-κB Activation in the Nod1/RICK and RIP Signaling Pathways , 2000 .

[216]  William C. Parks,et al.  Secretion of microbicidal α-defensins by intestinal Paneth cells in response to bacteria , 2000, Nature Immunology.

[217]  A. Israël,et al.  Complete lack of NF-kappaB activity in IKK1 and IKK2 double-deficient mice: additional defect in neurulation. , 2000, Genes & development.

[218]  A. Ciechanover,et al.  SCFβ‐TrCP ubiquitin ligase‐mediated processing of NF‐κB p 105 requires phosphorylation of its C‐terminus by IκB kinase , 2000 .

[219]  J. Renauld,et al.  Bcl-3 Expression Promotes Cell Survival following Interleukin-4 Deprivation and Is Controlled by AP1 and AP1-Like Transcription Factors , 2000, Molecular and Cellular Biology.

[220]  M. Connelly,et al.  Functional Isoforms of IκB Kinase α (IKKα) Lacking Leucine Zipper and Helix-Loop-Helix Domains Reveal that IKKα and IKKβ Have Different Activation Requirements , 2000, Molecular and Cellular Biology.

[221]  M. Kelliher,et al.  The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation. , 2000, Immunity.

[222]  T. Mak,et al.  Severe liver degeneration and lack of NF-kappaB activation in NEMO/IKKgamma-deficient mice. , 2000, Genes & development.

[223]  E. Schaeffer,et al.  PKC-θ is required for TCR-induced NF-κB activation in mature but not immature T lymphocytes , 2000, Nature.

[224]  T. Okamoto,et al.  Evidence for regulation of NF-kappaB by poly(ADP-ribose) polymerase. , 2000, The Biochemical journal.

[225]  G Cantarella,et al.  Recruitment of the IKK signalosome to the p55 TNF receptor: RIP and A20 bind to NEMO (IKKgamma) upon receptor stimulation. , 2000, Immunity.

[226]  W. Tam,et al.  Cytoplasmic Sequestration of Rel Proteins by IκBα Requires CRM1-Dependent Nuclear Export , 2000, Molecular and Cellular Biology.

[227]  Michael Karin,et al.  The IκB kinase (IKK) and NF-κB: key elements of proinflammatory signalling , 2000 .

[228]  P. Barton,et al.  Isolation, sequence, and chromosomal localisation of the human IκBR gene (NFKBIL2) , 2000, Annals of human genetics.

[229]  S. Smale,et al.  Rapid and selective remodeling of a positioned nucleosome during the induction of IL-12 p40 transcription. , 1999, Immunity.

[230]  H. Pahl Activators and target genes of Rel/NF-κB transcription factors , 1999, Oncogene.

[231]  David M. Rothwarf,et al.  The NF-κB Activation Pathway: A Paradigm in Information Transfer from Membrane to Nucleus , 1999, Science's STKE.

[232]  S. Ghosh,et al.  β-TrCP Mediates the Signal-induced Ubiquitination of IκBβ* , 1999, The Journal of Biological Chemistry.

[233]  K. Nakayama,et al.  Common Pathway for the Ubiquitination of IκBα, IκBβ, and IκBε Mediated by the F-Box Protein FWD1* , 1999, The Journal of Biological Chemistry.

[234]  C. Scheidereit,et al.  NF‐κB p105 is a target of IκB kinases and controls signal induction of Bcl‐3–p50 complexes , 1999 .

[235]  C. Ware,et al.  Targeted disruption of Traf5 gene causes defects in CD40- and CD27-mediated lymphocyte activation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[236]  R. Corley,et al.  Constitutive Nuclear Translocation of NF-κB in B Cells in the Absence of IκB Degradation , 1999, The Journal of Immunology.

[237]  T. Deerinck,et al.  The IKKβ Subunit of IκB Kinase (IKK) is Essential for Nuclear Factor κB Activation and Prevention of Apoptosis , 1999, The Journal of experimental medicine.

[238]  Sakae Tanaka,et al.  Severe osteopetrosis, defective interleukin‐1 signalling and lymph node organogenesis in TRAF6‐deficient mice , 1999, Genes to cells : devoted to molecular & cellular mechanisms.

[239]  I. Verma,et al.  IKK1-deficient mice exhibit abnormal development of skin and skeleton. , 1999, Genes & development.

[240]  A. Ciechanover,et al.  Structural Motifs Involved in Ubiquitin-Mediated Processing of the NF-κB Precursor p105: Roles of the Glycine-Rich Region and a Downstream Ubiquitination Domain , 1999, Molecular and Cellular Biology.

[241]  T. Serikawa,et al.  Alymphoplasia is caused by a point mutation in the mouse gene encoding Nf-κb-inducing kinase , 1999, Nature Genetics.

[242]  S. Morony,et al.  TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. , 1999, Genes & development.

[243]  S. Akira,et al.  Limb and skin abnormalities in mice lacking IKKalpha. , 1999, Science.

[244]  Inder M. Verma,et al.  Severe Liver Degeneration in Mice Lacking the IκB Kinase 2 Gene , 1999 .

[245]  Michael Karin,et al.  Positive and Negative Regulation of IκB Kinase Activity Through IKKβ Subunit Phosphorylation , 1999 .

[246]  T. Deerinck,et al.  Abnormal Morphogenesis But Intact IKK Activation in Mice Lacking the IKKα Subunit of IκB Kinase , 1999 .

[247]  D. Goeddel,et al.  Embryonic Lethality, Liver Degeneration, and Impaired NF-κB Activation in IKK-β-Deficient Mice , 1999 .

[248]  Y. Xiong,et al.  HOS, a human homolog of Slimb, forms an SCF complex with Skp1 and Cullin1 and targets the phosphorylation-dependent degradation of IκB and β-catenin , 1999, Oncogene.

[249]  R. Benarous,et al.  Inducible Degradation of IκBα by the Proteasome Requires Interaction with the F-box Protein h-βTrCP* , 1999, The Journal of Biological Chemistry.

[250]  Hiroshi Suzuki,et al.  IκBα Ubiquitination Is Catalyzed by an SCF-like Complex Containing Skp1, Cullin-1, and Two F-Box/WD40-Repeat Proteins, βTrCP1 and βTrCP2 , 1999 .

[251]  D. Wallach,et al.  Identification of a cell protein (FIP-3) as a modulator of NF-κB activity and as a target of an adenovirus inhibitor of tumor necrosis factor α-induced apoptosis , 1999 .

[252]  M. Mann,et al.  IκB Kinase (IKK)-Associated Protein 1, a Common Component of the Heterogeneous IKK Complex , 1999, Molecular and Cellular Biology.

[253]  Zhijian J. Chen,et al.  Signal-induced ubiquitination of IκBα by the F-box protein Slimb/β-TrCP , 1999 .

[254]  Stephen J. Elledge,et al.  The SCFβ-TRCP–ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IκBα and β-catenin and stimulates IκBα ubiquitination in vitro , 1999 .

[255]  B. Kahn-Perlès,et al.  Physical interaction of the bHLH LYL1 protein and NF-κB1 p105 , 1999, Oncogene.

[256]  M. Mann,et al.  Identification of the receptor component of the IκBα–ubiquitin ligase , 1998, Nature.

[257]  A. Baldwin,et al.  Activation of Nuclear Factor-κB-dependent Transcription by Tumor Necrosis Factor-α Is Mediated through Phosphorylation of RelA/p65 on Serine 529* , 1998, The Journal of Biological Chemistry.

[258]  Xin Lin,et al.  Molecular Determinants of NF-κB-Inducing Kinase Action , 1998, Molecular and Cellular Biology.

[259]  R. Bravo,et al.  Functional Redundancy of the Nuclear Factor κB Inhibitors IκBα and IκBβ , 1998, The Journal of experimental medicine.

[260]  E. Zandi,et al.  IKK-γ is an essential regulatory subunit of the IκB kinase complex , 1998, Nature.

[261]  E. Zandi,et al.  NF-κB-inducing Kinase and IκB Kinase Participate in Human T-cell Leukemia Virus I Tax-mediated NF-κB Activation* , 1998, The Journal of Biological Chemistry.

[262]  G. Courtois,et al.  Complementation Cloning of NEMO, a Component of the IκB Kinase Complex Essential for NF-κB Activation , 1998, Cell.

[263]  S. Ghosh,et al.  Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. , 1998, Molecular cell.

[264]  Zhaodan Cao,et al.  NF-κB-inducing kinase activates IKK-α by phosphorylation of Ser-176 , 1998 .

[265]  W. Greene,et al.  Cotranslational Biogenesis of NF-κB p50 by the 26S Proteasome , 1998, Cell.

[266]  Stefan Grimm,et al.  The Death Domain Kinase RIP Mediates the TNF-Induced NF-κB Signal , 1998 .

[267]  T. McKeithan,et al.  Diverse Effects of BCL3 Phosphorylation on Its Modulation of NF-κB p52 Homodimer Binding to DNA* , 1997, The Journal of Biological Chemistry.

[268]  D. Thanos,et al.  Cloning and functional characterization of mouse IkappaBepsilon. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[269]  S. Dower,et al.  Activation of Nuclear Transcription Factor NF-κB by Interleukin-1 Is Accompanied by Casein Kinase II-mediated Phosphorylation of the p65 Subunit* , 1997, The Journal of Biological Chemistry.

[270]  Z. Cao,et al.  MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. , 1997, Immunity.

[271]  D. Goeddel,et al.  Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. , 1997, Immunity.

[272]  Mike Rothe,et al.  IκB Kinase-β: NF-κB Activation and Complex Formation with IκB Kinase-α and NIK , 1997 .

[273]  Matthias Mann,et al.  IKK-1 and IKK-2: Cytokine-Activated IκB Kinases Essential for NF-κB Activation , 1997 .

[274]  E. Zandi,et al.  The IκB Kinase Complex (IKK) Contains Two Kinase Subunits, IKKα and IKKβ, Necessary for IκB Phosphorylation and NF-κB Activation , 1997, Cell.

[275]  P. Kuo,et al.  Alteration of NF-κB p50 DNA Binding Kinetics by S-Nitrosylation☆ , 1997 .

[276]  David M. Rothwarf,et al.  A cytokine-responsive IκB kinase that activates the transcription factor NF-κB , 1997, Nature.

[277]  H. Erdjument-Bromage,et al.  The Transcriptional Activity of NF-κB Is Regulated by the IκB-Associated PKAc Subunit through a Cyclic AMP–Independent Mechanism , 1997, Cell.

[278]  M. Karin,et al.  Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. , 1997, The New England journal of medicine.

[279]  A. Sher,et al.  Critical roles for the Bcl-3 oncoprotein in T cell-mediated immunity, splenic microarchitecture, and germinal center reactions. , 1997, Immunity.

[280]  A. Israël,et al.  I kappa B epsilon, a novel member of the IκB family, controls RelA and cRel NF‐κB activity , 1997 .

[281]  I. Verma,et al.  Immunological defects in mice with a targeted disruption in Bcl-3. , 1997, Genes & development.

[282]  B. Seed,et al.  RIP mediates tumor necrosis factor receptor 1 activation of NF‐kappaB but not Fas/APO‐1‐initiated apoptosis. , 1996, The EMBO journal.

[283]  Zhaodan Cao,et al.  TRAF6 is a signal transducer for interleukin-1 , 1996, Nature.

[284]  S. Ghosh,et al.  A glycine-rich region in NF-kappaB p105 functions as a processing signal for the generation of the p50 subunit , 1996, Molecular and cellular biology.

[285]  J. Caamaño,et al.  Constitutive expression of Bc1-3 in thymocytes increases the DNA binding of NF-kappaB1 (p50) homodimers in vivo , 1996, Molecular and cellular biology.

[286]  A. Israël,et al.  Phosphorylation of p105 PEST Sequences via a Redox-insensitive Pathway Up-regulates Processing to p50 NF-B (*) , 1996, The Journal of Biological Chemistry.

[287]  Hong-Bing Shu,et al.  TRADD–TRAF2 and TRADD–FADD Interactions Define Two Distinct TNF Receptor 1 Signal Transduction Pathways , 1996, Cell.

[288]  D. Baltimore,et al.  Constitutive NF-kappa B activation, enhanced granulopoiesis, and neonatal lethality in I kappa B alpha-deficient mice. , 1995, Genes & development.

[289]  E M Schwarz,et al.  Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. , 1995, Genes & development.

[290]  A. Ciechanover,et al.  Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[291]  T. Maniatis,et al.  Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway. , 1995, Genes & development.

[292]  B. Franza,et al.  RelA/p65 is a molecular target for the immunosuppressive action of protein kinase A. , 1995, The EMBO journal.

[293]  H. Erdjument-Bromage,et al.  IκB-β regulates the persistent response in a biphasic activation of NF-κB , 1995, Cell.

[294]  F. Weih,et al.  Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family , 1995, Cell.

[295]  U. Siebenlist,et al.  Activation of NF-kappa B requires proteolysis of the inhibitor I kappa B-alpha: signal-induced phosphorylation of I kappa B-alpha alone does not release active NF-kappa B. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[296]  C. Scheidereit,et al.  Activation of NF‐kappa B in vivo is regulated by multiple phosphorylations. , 1994, The EMBO journal.

[297]  R. Campbell,et al.  Characterization of a novel gene in the human major histocompatibility complex that encodes a potential new member of the I kappa B family of proteins. , 1994, Human molecular genetics.

[298]  A. Israël,et al.  Promoter analysis of the gene encoding the I kappa B‐alpha/MAD3 inhibitor of NF‐kappa B: positive regulation by members of the rel/NF‐kappa B family. , 1993, The EMBO journal.

[299]  S. Goodbourn,et al.  Proteolytic degradation of MAD3 (IϰBα) and enhanced processing of the NF-ϰB precursor p105 are obligatory steps in the activation of NF-ϰB , 1993 .

[300]  A. Baldwin,et al.  The I kappa B proteins: multifunctional regulators of Rel/NF-kappa B transcription factors. , 1993, Genes & development.

[301]  V. Bours,et al.  The oncoprotein Bcl‐3 can facilitate NF‐kappa B‐mediated transactivation by removing inhibiting p50 homodimers from select kappa B sites. , 1993, The EMBO journal.

[302]  A. Baldwin,et al.  NF-kappa B p100 (Lyt-10) is a component of H2TF1 and can function as an I kappa B-like molecule , 1993, Molecular and cellular biology.

[303]  Y. Ben-Neriah,et al.  Rapid proteolysis of IκB-α is necessary for activation of transcription factor NF-κB , 1993, Nature.

[304]  G. Nolan,et al.  The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-kappa B p50 homodimers. , 1993, Genes & development.

[305]  F. Bach,et al.  Cytokine‐inducible expression in endothelial cells of an I kappa B alpha‐like gene is regulated by NF kappa B. , 1993, The EMBO journal.

[306]  G. Nolan,et al.  The bcl-3 proto-oncogene encodes a nuclear I kappa B-like molecule that preferentially interacts with NF-kappa B p50 and p52 in a phosphorylation-dependent manner , 1993, Molecular and cellular biology.

[307]  M. Karin,et al.  p105 and p98 precursor proteins play an active role in NF-kappa B-mediated signal transduction. , 1993, Genes & development.

[308]  W C Greene,et al.  NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway. , 1993, Science.

[309]  G. Franzoso,et al.  Mutual regulation of the transcriptional activator NF-kappa B and its inhibitor, I kappa B-alpha. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[310]  V. Bours,et al.  The oncoprotein Bcl-3 directly transactivates through κB motifs via association with DNA-binding p50B homodimers , 1993, Cell.

[311]  C. Scheidereit,et al.  The NF‐kappa B precursor p105 and the proto‐oncogene product Bcl‐3 are I kappa B molecules and control nuclear translocation of NF‐kappa B. , 1993, The EMBO journal.

[312]  A. Israël,et al.  The precursor of NF-κB p50 has IκB-like functions , 1992, Cell.

[313]  C. Scheidereit,et al.  Candidate proto-oncogene bcl-3 encodes a subunit-specific inhibitor of transcription factor NF-κB , 1992, Nature.

[314]  I. Verma,et al.  IκBγ, a 70 kd protein identical to the C-terminal half of p110 NF-κB: A new member of the IκB family , 1992, Cell.

[315]  C. Scheidereit,et al.  The ankyrin repeat domains of the NF-kappa B precursor p105 and the protooncogene bcl-3 act as specific inhibitors of NF-kappa B DNA binding. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[316]  T. Maniatis,et al.  Generation of p50 subunit of NF-kB by processing of p105 through an ATP-dependent pathway , 1991, Nature.

[317]  I. Verma,et al.  The rel-associated pp40 protein prevents DNA binding of Rel and NF-kappa B: relationship with I kappa B beta and regulation by phosphorylation. , 1991, Genes & development.

[318]  S. Haskill,et al.  Characterization of an immediate-early gene induced in adherent monocytes that encodes IκB-like activity , 1991, Cell.

[319]  G. Nolan,et al.  DNA binding and IκB inhibition of the cloned p65 subunit of NF-κB, a rel-related polypeptide , 1991, Cell.

[320]  P. Baeuerle,et al.  The 65-kD subunit of NF-kappa B is a receptor for I kappa B and a modulator of DNA-binding specificity. , 1990, Genes & development.

[321]  D. Baltimore,et al.  Activation in vitro of NF-κB" by phosphorylation of its inhibitor IκB" , 1990, Nature.

[322]  H. Ohno,et al.  The candidate proto-oncogene bcl-3 is related to genes implicated in cell lineage determination and cell cycle control , 1990, Cell.

[323]  D. Baltimore,et al.  NF-κB: A pleiotropic mediator of inducible and tissue-specific gene control , 1989, Cell.

[324]  M. Pasparakis,et al.  NF-κB in the regulation of epithelial homeostasis and inflammation , 2011, Cell Research.

[325]  V. Dixit,et al.  Deubiquitinases in the regulation of NF-κB signaling , 2011, Cell Research.

[326]  G. Courtois,et al.  IKK regulation and human genetics. , 2011, Current topics in microbiology and immunology.

[327]  J. Sundberg,et al.  Inhibition of NF-κB signaling retards eosinophilic dermatitis in SHARPIN-deficient mice. , 2011, The Journal of investigative dermatology.

[328]  S. Ley,et al.  Regulation and function of TPL-2, an IκB kinase-regulated MAP kinase kinase kinase , 2011, Cell Research.

[329]  C. Zeiss,et al.  Constitutively active NF-kB triggers systemic TNFa-dependent inflammation and localized TNFa-independent inflammatory disease , 2010 .

[330]  M. Belich,et al.  Proteolysis of NF-κB1 p105 is essential for T cell antigen receptor–induced proliferation , 2009, Nature Immunology.

[331]  W. Schneider-Brachert,et al.  Impact of TNF-R1 and CD95 internalization on apoptotic and antiapoptotic signaling. , 2009, Results and problems in cell differentiation.

[332]  Michael Karin,et al.  NF-kB as a Critical Link Between Inflammation and Cancer , 2009 .

[333]  A. Hoffmann,et al.  A Fourth IkB Protein within the NF-kB Signaling Module , 2007 .

[334]  R. Strosznajder,et al.  Poly(ADP-ribose) polymerase , 2007, Molecular Neurobiology.

[335]  H. Kuwata,et al.  IkappaBNS inhibits induction of a subset of Toll-like receptor-dependent genes and limits inflammation. , 2006, Immunity.

[336]  Zheng‐gang Liu,et al.  Molecular mechanism of TNF signaling and beyond , 2005, Cell Research.

[337]  H. Young,et al.  BCL-3 and NF-kappaB p50 attenuate lipopolysaccharide-induced inflammatory responses in macrophages. , 2004, The Journal of biological chemistry.

[338]  M. Robinson,et al.  Kinase Mitogen-activated Protein Kinase Tpl-2/mek/extracellular Signal-regulated Lipopolysaccharide Activation of the Supplemental Material , 2004 .

[339]  A. Hoffmann,et al.  Nucleosome remodeling at the IL-12 p40 promoter is a TLR-dependent, Rel-independent event , 2001, Nature Immunology.

[340]  M J May,et al.  NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. , 1998, Annual review of immunology.

[341]  M. Merika,et al.  Distinct Functional Properties of IkBa and IkBb , 1997 .

[342]  H. Suyang,et al.  Role of unphosphorylated, newly synthesized IκBβ in persistent activation of NF-κB , 1996 .

[343]  E. Harhaj,et al.  Inhibition of p105 processing by NF-kappaB proteins in transiently transfected cells. , 1996, Oncogene.

[344]  K. Fujimoto,et al.  A role for phosphorylation in the proteolytic processing of the human NF-kappa B1 precursor. , 1995, Gene.

[345]  P. Baeuerle,et al.  Function and activation of NF-kappa B in the immune system. , 1994, Annual review of immunology.

[346]  G. Franzoso,et al.  Structure, regulation and function of NF-kappa B. , 1994, Annual review of cell biology.

[347]  A. Hoffmann,et al.  The I (cid:1) B –NF-(cid:1) B Signaling Module: Temporal Control and Selective Gene Activation , 2022 .